22nd Century
XXII | NASDAQ
$0.51
-$0.26 (-33.77%)
At close: Nov 16, 2026, 3:59 PM ET
$0.48
-$0.03 (-5.88%)
After-hours:
Nov 16, 2026, 7:59 PM ET
22nd Century Company Profile
Company profile explainedCompany Profile
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Key Executives
| Name | Position |
|---|---|
| Lawrence D. Firestone | President, Chief Executive Officer & Chairman |
| Daniel A. Otto | Chief Financial Officer & Principal Accounting Officer |
| James C. Morrison | Technical Advisor & Regulatory Affairs Consultant |
| Jonathan Staffeldt | General Counsel & Secretary |
| Katherine Rouse-Bailey | Vice President of Marketing |
| Kimberly Farr | Director of Science & Technology |
| Matthew Kreps | Investor Relations |
| Robert Manfredonia | Executive Vice President of Sales |
| Scott Marion | Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 03, 2026 | 8-K | Current Report |
| Oct 28, 2026 | 8-K | Current Report |
| Oct 28, 2026 | 424B5 | Filing |
| Oct 23, 2026 | 424B5 | Filing |
| Oct 23, 2026 | 8-K | Current Report |
| Oct 22, 2026 | 8-K | Current Report |
| Sep 01, 2026 | 8-K | Current Report |
| Aug 25, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 20, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 20, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
22nd Century
| Country | United States |
| IPO Date | Jan 26, 2011 |
| Industry | Tobacco |
| Sector | Consumer Defensive |
| Employees | 32 |
| CEO | Lawrence D. Firestone |
Contact Details
321 Farmington Road Mocksville,
New York 27028 United States
Stock Details
| Ticker Symbol | XXII |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001347858 |
| CUSIP Number | 90137F806 |
| ISIN Number | US90137F8068 |
| SIC Code | 2111 |
Recent News
- 13 days ago / globenewswire.com22nd Century Group to Announce Third Quarter 2026 Results on November 16, 2026
- 18 days ago / globenewswire.com22nd Century Signs Groundbreaking Agreement with Gopuff
- 19 days ago / globenewswire.com22nd Century Group Expands Pinnacle Brand Into 13 Newly Authorized States, Adding an Expected 360 Stores Nationwide for Pinnacle VLN® and Pinnacle Pure
- 22 days ago / globenewswire.com22nd Century Expands the Pinnacle Pure Portfolio To 6 SKU's With Addition of 100's and Menthol Varieties
- 26 days ago / globenewswire.com22nd Century Group Preliminarily Reports Third Quarter Financial Results
- 1 month ago / globenewswire.com22nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161%
- 2 months ago / globenewswire.com22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
- 2 months ago / globenewswire.com22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule
- 3 months ago / globenewswire.com22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter
- 3 months ago / globenewswire.com22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026
Add to Watchlist
Select watchlists to add or remove XXII